News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Geron Corporation Appoints Hoyoung Huh and Robert Spiegel to Its Board of Directors
May 20, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) today announced the appointment of Hoyoung Huh, M.D., Ph.D. and Robert J. Spiegel, M.D., FACP to its board of directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
IN PARTNERSHIP WITH INTELLIA THERAPEUTICS
The commercial launch playbook: Team structure, readiness and execution
June 15, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Layoff Tracker
Genentech R&D cuts include longtime top exec
June 12, 2026
·
59 min read
·
BioSpace Editorial Staff
Manufacturing
FDA imposes import alert on Indian plant after inspectors flag GMP failings
June 12, 2026
·
2 min read
·
Nick Paul Taylor
Rare diseases
Amgen shores up Tavneos’ FDA defense with Duke data analysis
June 12, 2026
·
2 min read
·
Tristan Manalac
